AAAAAA

   
Results: 1-9 |
Results: 9
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE NOVEL ANTITUMORDRUG, BRYOSTATIN-1, INCORPORATING A SERUM EXTRACTION TECHNIQUE
Authors: KHAN P MCGOWN AT DAWSON MJ JAYSON G PRENDIVILLE JA PETTIT GR CROWTHER D
Citation: P. Khan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE NOVEL ANTITUMORDRUG, BRYOSTATIN-1, INCORPORATING A SERUM EXTRACTION TECHNIQUE, Journal of chromatography B. Biomedical sciences and applications, 709(1), 1998, pp. 113-117
BRYOSTATIN 1-TAMOXIFEN COMBINATIONS SHOW SYNERGISTIC EFFECTS ON THE INHIBITION OF GROWTH OF P388 CELLS IN-VITRO
Authors: MCGOWN AT JAYSON G PETTIT GR HARAN MS WARD TH CROWTHER D
Citation: At. Mcgown et al., BRYOSTATIN 1-TAMOXIFEN COMBINATIONS SHOW SYNERGISTIC EFFECTS ON THE INHIBITION OF GROWTH OF P388 CELLS IN-VITRO, British Journal of Cancer, 77(2), 1998, pp. 216-220
REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - STUDIES EXCLUDING TAXANES
Authors: CLEMONS M LEAHY M VALLE J JAYSON G RANSON M HAYES S HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - STUDIES EXCLUDING TAXANES, European journal of cancer, 33(13), 1997, pp. 2171-2182
REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - THE TAXANES
Authors: CLEMONS M LEAHY M VALLE J JAYSON G RANSON M HOWELL A
Citation: M. Clemons et al., REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - THE TAXANES, European journal of cancer, 33(13), 1997, pp. 2183-2193
SINGLE-AGENT PACLITAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER - SINGLE-CENTER PHASE-II STUDY USING A 3-HOUR ADMINISTRATION SCHEDULE
Authors: RANSON MR JAYSON G PERKINS S ANDERSON H THATCHER N
Citation: Mr. Ranson et al., SINGLE-AGENT PACLITAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER - SINGLE-CENTER PHASE-II STUDY USING A 3-HOUR ADMINISTRATION SCHEDULE, Seminars in oncology, 24(4), 1997, pp. 6-9
GEMCITABINE - SYMPTOMATIC BENEFIT IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: THATCHER N JAYSON G BRADLEY B RANSON M ANDERSON H
Citation: N. Thatcher et al., GEMCITABINE - SYMPTOMATIC BENEFIT IN ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 86-812
A RANDOMIZED TRIAL INVESTIGATING THE DOSE INTENSITY OF PRIMARY CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA - A COMPARISON OF CHEMOTHERAPY GIVEN EVERY 4 WEEKS WITH THE SAME CHEMOTHERAPY GIVEN AT 3 WEEK INTERVALS
Authors: WRIGLEY E WEAVER A JAYSON G RANSON M RENNINSON J PRENDIVILLE J DOBSON M COLLINS CD SWINDELL R BUCKLEY CH RADFORD JA CROWTHER D
Citation: E. Wrigley et al., A RANDOMIZED TRIAL INVESTIGATING THE DOSE INTENSITY OF PRIMARY CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA - A COMPARISON OF CHEMOTHERAPY GIVEN EVERY 4 WEEKS WITH THE SAME CHEMOTHERAPY GIVEN AT 3 WEEK INTERVALS, Annals of oncology, 7(7), 1996, pp. 705-711
CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ALPHA-2B INTERFERON FOR ADVANCED COLORECTAL-CARCINOMA
Authors: FERGUSON JE HULSE P LORIGAN P JAYSON G SCARFFE JH
Citation: Je. Ferguson et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ALPHA-2B INTERFERON FOR ADVANCED COLORECTAL-CARCINOMA, British Journal of Cancer, 72(1), 1995, pp. 193-197
IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO
Authors: SCHEID C PRENDIVILLE J JAYSON G CROWTHER D FOX B PETTIT GR STERN PL
Citation: C. Scheid et al., IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 223-230
Risultati: 1-9 |